157 related articles for article (PubMed ID: 35241529)
1. Secretory Phospholipase A2 Digital Expression Analysis in Colon Adenocarcinoma.
Falidas E; Kitsiouli E; Spyropoulou D; Tsiambas E; Kalogirou A; Tsouvelas G; Papadopoulos S; Mitsis M; Lekka M; Mastronikoli S; Peschos D; Dimas O; Vlachos K
In Vivo; 2022; 36(2):738-742. PubMed ID: 35241529
[TBL] [Abstract][Full Text] [Related]
2. Impact of peroxiredoxin-6 expression on colon adenocarcinoma.
Falidas E; Kitsiouli E; Tsounis D; Kalogirou A; Tsiambas E; Tsouvelas G; Papadopoulos S; Mitsis M; Lekka M; Vlachos K
J BUON; 2021; 26(5):1893-1897. PubMed ID: 34761597
[TBL] [Abstract][Full Text] [Related]
3. Secretory Phospholipase A
Sharma SK; Yadav SK; Sharma U; Avti P; Rana S; Khanduja KL
Anticancer Agents Med Chem; 2023; 23(4):450-460. PubMed ID: 35638274
[TBL] [Abstract][Full Text] [Related]
4. Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate.
Mounier CM; Wendum D; Greenspan E; Fléjou JF; Rosenberg DW; Lambeau G
Br J Cancer; 2008 Feb; 98(3):587-95. PubMed ID: 18212756
[TBL] [Abstract][Full Text] [Related]
5. Modulation of immunity by the secreted phospholipase A
Murakami M; Sato H; Taketomi Y
Immunol Rev; 2023 Aug; 317(1):42-70. PubMed ID: 37035998
[TBL] [Abstract][Full Text] [Related]
6. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.
Jiang J; Neubauer BL; Graff JR; Chedid M; Thomas JE; Roehm NW; Zhang S; Eckert GJ; Koch MO; Eble JN; Cheng L
Am J Pathol; 2002 Feb; 160(2):667-71. PubMed ID: 11839587
[TBL] [Abstract][Full Text] [Related]
7. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus.
Lagorce-Pagès C; Paraf F; Wendum D; Martin A; Fléjou JF
Virchows Arch; 2004 May; 444(5):426-35. PubMed ID: 15045585
[TBL] [Abstract][Full Text] [Related]
8. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA SLNCR1 regulates non‑small cell lung cancer migration, invasion and stemness through interactions with secretory phospholipase A2.
Xu W; Xu Q; Kuang D; Wang Z; Lu Q; Lin Q; Wu H; Chen L
Mol Med Rep; 2019 Sep; 20(3):2591-2596. PubMed ID: 31524254
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional characterization of a thermostable secretory phospholipase A
Kang BG; Kwon SY; Lee HR; Hwang Y; Youn SY; Oh C; Park JB; Cha SS
Acta Crystallogr D Struct Biol; 2023 Feb; 79(Pt 2):188-197. PubMed ID: 36762864
[TBL] [Abstract][Full Text] [Related]
11. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.
Tribler L; Jensen LT; Jørgensen K; Brünner N; Gelb MH; Nielsen HJ; Jensen SS
Anticancer Res; 2007; 27(5A):3179-85. PubMed ID: 17970059
[TBL] [Abstract][Full Text] [Related]
12. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids.
Leitinger N; Watson AD; Hama SY; Ivandic B; Qiao JH; Huber J; Faull KF; Grass DS; Navab M; Fogelman AM; de Beer FC; Lusis AJ; Berliner JA
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782
[TBL] [Abstract][Full Text] [Related]
13. Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction.
Arbibe L; Koumanov K; Vial D; Rougeot C; Faure G; Havet N; Longacre S; Vargaftig BB; Béréziat G; Voelker DR; Wolf C; Touqui L
J Clin Invest; 1998 Sep; 102(6):1152-60. PubMed ID: 9739049
[TBL] [Abstract][Full Text] [Related]
14. Phospholipase A2 in chamber angle of normal eyes and patients with primary open angle glaucoma and exfoliation glaucoma.
Rönkkö S; Rekonen P; Kaarniranta K; Puustjarvi T; Teräsvirta M; Uusitalo H
Mol Vis; 2007 Mar; 13():408-17. PubMed ID: 17417602
[TBL] [Abstract][Full Text] [Related]
15. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues.
Masuda S; Murakami M; Ishikawa Y; Ishii T; Kudo I
Biochim Biophys Acta; 2005 Oct; 1736(3):200-10. PubMed ID: 16188494
[TBL] [Abstract][Full Text] [Related]
16. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma.
Gorovetz M; Baekelandt M; Berner A; Trope' CG; Davidson B; Reich R
Gynecol Oncol; 2006 Dec; 103(3):831-40. PubMed ID: 16919315
[TBL] [Abstract][Full Text] [Related]
17. Secretory phospholipase A2 enzymes as pharmacological targets for treatment of disease.
Quach ND; Arnold RD; Cummings BS
Biochem Pharmacol; 2014 Aug; 90(4):338-48. PubMed ID: 24907600
[TBL] [Abstract][Full Text] [Related]
18. Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth.
Belinsky GS; Rajan TV; Saria EA; Giardina C; Rosenberg DW
Mol Carcinog; 2007 Feb; 46(2):106-16. PubMed ID: 17091473
[TBL] [Abstract][Full Text] [Related]
19. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.
Graff JR; Konicek BW; Deddens JA; Chedid M; Hurst BM; Colligan B; Neubauer BL; Carter HW; Carter JH
Clin Cancer Res; 2001 Dec; 7(12):3857-61. PubMed ID: 11751475
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of secretory phospholipase A2 IIa attenuates prostaglandin E2-induced invasiveness in lung adenocarcinoma.
Halpern AL; Kohtz PD; Rove JY; Ao L; Meng X; Fullerton DA; Weyant MJ
Mol Cell Biochem; 2019 Jun; 456(1-2):145-156. PubMed ID: 30684134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
